353822 <common-name>(10s,13s,16s,19s)-16-benzyl-11,14-dimethyl-3-(2-methylpropyl)-10,13-di(propan-2-yl)-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone</common-name> <description>(10s,13s,16s,19s)-16-benzyl-11,14-dimethyl-3-(2-methylpropyl)-10,13-di(propan-2-yl)-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone is a chemical compound with the formula C35H53N5O7. With an average molecular weight of 655.80 g/mol, (10s,13s,16s,19s)-16-benzyl-11,14-dimethyl-3-(2-methylpropyl)-10,13-di(propan-2-yl)-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>16680915</pubchem-id> <chemical-formula>C35H53N5O7</chemical-formula> <weight>655.8</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T20:56:30Z</created-at> <updated-at type="dateTime">2026-08-31T20:56:30Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)CC1C(=O)N2CCCC2C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)O1)C(C)C)C)C(C)C)C)CC3=CC=CC=C3</moldb-smiles> <moldb-formula>C35H53N5O7</moldb-formula> <moldb-inchi>InChI=1S/C35H53N5O7/c1-21(2)19-27-34(45)40-18-12-15-26(40)31(42)37-25(20-24-13-10-9-11-14-24)33(44)39(8)30(23(5)6)35(46)38(7)29(22(3)4)32(43)36-17-16-28(41)47-27/h9-11,13-14,21-23,25-27,29-30H,12,15-20H2,1-8H3,(H,36,43)(H,37,42)/t25-,26-,27?,29-,30-/m0/s1</moldb-inchi> <moldb-inchikey>RTZWJENDDHDLIV-UTKDJJAFSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">655.3944991</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM349715</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(10s,13s,16s,19s)-16-benzyl-11,14-dimethyl-3-(2-methylpropyl)-10,13-di(propan-2-yl)-4-oxa-1,8,11,14,17-pentazabicyclo[17.3.0]docosane-2,5,9,12,15,18-hexone</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Peptidomimetics</klass> <subklass>Depsipeptides</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0304104</sync-id> <structure-inchikey>RTZWJENDDHDLIV-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>44001000020000000000800000001000000000000000000000400010010000040000001000044020000108000000200004000000000000020020000000000000000000000080000010000000000000200020800000880000000000000002000000000000001000000000000000020000000000020100000400a00000000000100820000040600000800000200000024000000000020100000000000000000000000400008004000001000000080000000000000000008000008000000000001000800000000000000000000000000000000000400000020000200220000001000000000010000100002040000000000000000000000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAvAAAAMQAAAIABBgBgAAAAAQMGAGAAAAAD AQYAYAAAAAEDBgBgAAAAAgIGAGAAAAADAQYAKAAAAAMECAAoAAAAAwIHACgA AAADAwYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAMBBgAoAAAAAwQI ACgAAAADAgcAaAAAAAMCAQYAYAAAAAMBBgAoAAAAAwQIACgAAAADAgcAKAAA AAMDBgBgAAAAAwEGACgAAAADBAgAKAAAAAMCBwAoAAAAAwMGAGAAAAADAQYA KAAAAAMECAAoAAAAAwIHAGgAAAADAgEGAGAAAAACAgYAYAAAAAICBgAoAAAA AwQIACgAAAADAggAKAAAAAMCBgBgAAAAAwEGAGAAAAABAwYAYAAAAAEDBgBg AAAAAQMGAGAAAAADAQYAYAAAAAEDBgBgAAAAAQMGAGAAAAABAwYAYAAAAAIC BkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEG QGgAAAADAwELAAEAAQIAAQMAAwQABAUABQYoAgUHIAcIAAgJAAkKAAoLAAsM AAwNKAIMDiAODwAPEAAQESgCEBIgEhMAExQAFBUoAhQWIBYXABcYABgZKAIY GiAaGwAbHAAcHQAdHigCHR8gFyAAICEAICIAFiMAEyQAJCUAJCYAEicADygA KCkAKSpoDCoraAwrLGgMLC1oDC0uaAwfBAALBwAuKWgMQgMAAAATBAUHCwwO DxASExQWFxgaGxwdHwUIBwsKCQYqKywtLikXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:51:36Z</structure-indexed-at> </compound>